Glucagon-Like Peptide-2 (GLP-2) is a hormone produced in the intestines that plays a significant role in regulating various physiological processes, particularly those related to metabolism and ...

The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...

Rani Therapeutics (RANI) announced new pharmacokinetic and pharmacodynamic data from a preclinical study evaluating the oral delivery of the ...